Ad
BSTG Stock - Biostage Stock Trading
About | Biostage (OTCMKTS:BSTG)
Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company s Cellframe technology combines the synthetic scaffold with tissue engineering and cell biology to create method of addressing organ damage. Its Cellframe technology stimulates the body s signaling pathways and natural healing process to regenerate and restore organ function. The company is developing organ implants as a platform of being used in the esophagus, trachea, and bronchi. Its implants are being advanced and tested in a preclinical collaborative study with Mayo Clinic. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March . Biostage, Inc. was founded in and is headquartered in Holliston, Massachusetts.
Quote | Biostage (OTCMKTS:BSTG)
| Last: | $4.03 |
|---|---|
| Change Percent: | -2.31% |
| Open: | $4.0925 |
| Close: | $4.03 |
| High: | $4.14 |
| Low: | $4 |
| Volume: | 4,533 |
| Last Trade Date Time: | 07/19/2023 03:00:00 am |
News | Biostage (OTCMKTS:BSTG)
-
Holliston, MA, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs in...
-
Holliston, MA, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organ...
Message Board Posts | Biostage (OTCMKTS:BSTG)
| Subject | By | Source | When |
|---|---|---|---|
| NEWS !!! | Fedel | investorshub | 01/12/2022 5:02:31 PM |
| Has anything changed in the company at the moment? | Androped12 | investorshub | 09/07/2020 7:11:24 PM |
| Interesting chart. | jjr04001 | investorshub | 07/18/2020 4:34:34 PM |
| Whole management team a bunch of scumbags. Mcgorry | AKthisistheone | investorshub | 01/30/2019 1:48:29 PM |
| The mgmt is a bunch of liars. Their | spoiler | investorshub | 12/18/2018 12:51:31 PM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
Holliston, MA, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs in...
-
Holliston, MA, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organ...
-
Entered into securities purchase agreements with accredited investors for a $1.5 million private investment in public equity (PIPE) financing. The transaction closed on April 15, 2024. Received $0.5 million in convertible debt from Company’s CEO in February 2024. Hollisto...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...